Merck pairs up for Keytruda diagnostic; Multivir scraps IPO plot;

@FierceBiotech: The White House draws the line against CRISPR/Cas9-designed embryos. More from FierceBiotechResearch | Follow @FierceBiotech

@JohnCFierce: Seres ($MCRB), joins $ADAP, $ADRO, $CDTX, $JUNO, Molecular Partners and $ONCE among the 2014 Fierce 15 biotechs to go for an IPO. | Follow @JohnCFierce

> Merck ($MRK) inked a deal with diagnostics outfit NanoString Technologies ($NSTG) to craft an assay that will help identify ideal patients for Keytruda, the drugmaker's blockbuster-in-waiting cancer immunotherapy. More

> MultiVir, a gene therapy biotech formerly known as Introgen Therapeutics, nixed its plans to raise $60 million in an IPO. News

> Ultragenyx Pharmaceutical ($RARE) kicked off a Phase III trial of its extended-release aceneuramic acid, a treatment for a rare, muscle-destroying disease called GNE myopathy. Item

Medical Device News

@FierceMedDev: Roche's Ventana teams up with Halozyme for pancreatic cancer companion Dx. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Pacira's liposomal-encased bupivacaine gets positive reviews at breast cancer conference. FierceDrugDelivery report | Follow @VarunSaxena2

@EmilyWFierce: $SQNM is consolidating its labs. Release | Follow @EmilyWFierce

> Freedom Meditech, maker of diabetes eye scanner, raises $4.8M in Series C round. Article

> WSJ: J&J faces FBI probe over power morcellator devices. Report

Pharma News

@FiercePharma: ICYMI: As Bayer preps for its slim-down, a restructuring looms--but jobs are safe, CEO says. Article | Follow @FiercePharma

@CarlyHFierce: ICYMI: Top Medicare prescribers get top payments from drugmakers: Modern Healthcare. Report | Follow @CarlyHFierce

> FTC scores hefty $1.2B settlement in Teva pay-for-delay case. Report

> GI dealmaking pays off for Valeant, Actavis with same-day FDA nods in IBS. Story

Vaccines News

> World Health Assembly passes resolution on vaccine pricing, transparency. Item

> Serum Institute, Cipla partner to market flu vaccine in India. More

> Abivax seeks cash to bring Cuban-discovered HepB vaccine to the world. Story

> Hold the offer: Bavarian Nordic declares it's not for sale. Article

> Regeneus gets green light to move personalized cancer vaccine into PhI. Report

CRO News

> Parexel rejigs its randomization tech with an eye on speed. Item

> BioClinica partners up for risk-based management. More

> Ergomed snags a postmarketing firm with its eye on pharmacovigilance. Article

> EMA still wants 700 GVK-related drugs off the market. Story

> Quintiles homes in on Asian biotech with its latest offering. Report

Pharma Manufacturing News

> Bayer set to spend $3.4M this year to expand its Indonesian operations. Story

> Report: Claris Lifesciences injectables sale may hit roadblock by FDA Form 483. Item

> Aurobindo Pharma submits abbreviated application to FDA for HIV drug production. News

> Gerresheimer Glass to close NJ pharmaceutical bottle plant this summer. Article

> Gilead Sciences plans $100M expansion of Edmonton plant. Report

Pharma Asia News

> Singapore clinical hub to work with Visterra on dengue candidate. More

> TPP negotiators said to be zeroing in on clearing IP snags. Story

> Japan's cabinet tells health minister to dig deeper on costs. Article

> China to charge $102K for drug, device registration in first hike in two years. Item

> Russia makes it easier to skirt imported drug sale norms. Report